Home > Boards > US OTC > Medical - Drugs > Petlife Pharmaceuticals Inc. (PTLF)

8-K filed in AH yesterday...

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
CrazyC Member Profile
 
Followed By 10
Posts 563
Boards Moderated 0
Alias Born 09/12/02
160x600 placeholder
CrazyC   Friday, 01/17/20 07:48:40 AM
Re: None
Post # of 3032 
8-K filed in AH yesterday...

https://www.sec.gov/Archives/edgar/data/1354591/000149315220000695/form8-k.htm

Quote:
Item 2.01 Completion of acquisition or disposition of assets

Petlife Pharmaceuticals, Inc. and Red Rock Alternative Fund LLC. (“RRAF”) have entered into an Agreement dated January 15, 2020, whereby Petlife will purchase a controlling interest in a new joint venture to grow, market and sell hemp products. In order to effectuate the joint venture, the parties have established a new company, THE MAYE INTERNATIONAL GROUP SARL (“NEWCO”), fifty-one (51) percent of which is owned by Petlife and forty-nine (49) percent is owned by Company; RRAF has irrevocably assigned to NEWCO, two thousand (2,000) hectares of private lands of Land in the Democratic Republic of Congo (DRC); such land has a lease term of at least 6 years. In consideration for the asset, Petlife shall transfer five hundred million (500,000,000) common shares of Petlife to Company in two stages; a.) 250 Million upon signing the JV b.) 250 Million upon the land being planted with Hemp Seeds.

Petlife’s previous business was engaged in the research, development, sales, and support of drugs and nutraceuticals for pet cancer and autoimmune related diseases; Petlife will entirely change its course of business to participate in this joint venture; Petlife believes that this joint venture is in the best interest of the company and the shareholders.

Petlife anticipates a company name change after the new management has been appointed to more accurately reflect the new nature of the business.

Upon the issuance of 500,000,000 restricted shares of common stock by the Company to Company pursuant to the Joint Venture Agreement (See Item 1.01 – Entry into a Material Definitive Agreement, above), a change of control will take place. The shares involved in the transactions constitute approximately 65% of the Company’s currently issued and outstanding shares of common stock.

Petlife will institute a management change within 30 days of January 15, 2020. Upon appointment of new management, Sebastian Serrell-Watts will concurrently resign as Chief Executive Office, President, Secretary, Treasurer, Chief Financial Officer, and a Director of the Company.




https://www.youtube.com/watch?v=EXyGY-mFVHY

DISCLAIMER: Anything that I may post should be viewed as a personal opinion. Do not misconstrue these opinions as investment or trading advice. All posts are for entertainment purposes only!
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist